Cargando…

Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis

Detalles Bibliográficos
Autores principales: Wallwork, Rachel, Connolly, Caoilfhionn M, Shneyderman, Matthew, McMahan, Zsuzsanna, Mecoli, Christopher A, Wigley, Fredrick, Hummers, Laura K, Shah, Ami A, Paik, Julie J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045742/
https://www.ncbi.nlm.nih.gov/pubmed/35502180
http://dx.doi.org/10.1016/S2665-9913(22)00100-X
_version_ 1784695379904692224
author Wallwork, Rachel
Connolly, Caoilfhionn M
Shneyderman, Matthew
McMahan, Zsuzsanna
Mecoli, Christopher A
Wigley, Fredrick
Hummers, Laura K
Shah, Ami A
Paik, Julie J
author_facet Wallwork, Rachel
Connolly, Caoilfhionn M
Shneyderman, Matthew
McMahan, Zsuzsanna
Mecoli, Christopher A
Wigley, Fredrick
Hummers, Laura K
Shah, Ami A
Paik, Julie J
author_sort Wallwork, Rachel
collection PubMed
description
format Online
Article
Text
id pubmed-9045742
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90457422022-04-28 Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis Wallwork, Rachel Connolly, Caoilfhionn M Shneyderman, Matthew McMahan, Zsuzsanna Mecoli, Christopher A Wigley, Fredrick Hummers, Laura K Shah, Ami A Paik, Julie J Lancet Rheumatol Comment Elsevier Ltd. 2022-07 2022-04-27 /pmc/articles/PMC9045742/ /pubmed/35502180 http://dx.doi.org/10.1016/S2665-9913(22)00100-X Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Wallwork, Rachel
Connolly, Caoilfhionn M
Shneyderman, Matthew
McMahan, Zsuzsanna
Mecoli, Christopher A
Wigley, Fredrick
Hummers, Laura K
Shah, Ami A
Paik, Julie J
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
title Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
title_full Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
title_fullStr Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
title_full_unstemmed Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
title_short Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
title_sort effect of mycophenolate mofetil dose on antibody response following initial sars-cov-2 vaccination in patients with systemic sclerosis
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045742/
https://www.ncbi.nlm.nih.gov/pubmed/35502180
http://dx.doi.org/10.1016/S2665-9913(22)00100-X
work_keys_str_mv AT wallworkrachel effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis
AT connollycaoilfhionnm effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis
AT shneydermanmatthew effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis
AT mcmahanzsuzsanna effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis
AT mecolichristophera effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis
AT wigleyfredrick effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis
AT hummerslaurak effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis
AT shahamia effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis
AT paikjuliej effectofmycophenolatemofetildoseonantibodyresponsefollowinginitialsarscov2vaccinationinpatientswithsystemicsclerosis